A61P 1/04
Drugs for disorders of the alimentary tract or the digestive system: for
Official title: for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
A61P1/04 (Drugs for disorders of the alimentary tract or the digestive system: for) appears on 19,473 US grants and 28,406 published applications in this corpus.
Search patents in A61P- Granted patents
- 19,473
- Published applications
- 28,406
- Assignees
- 6,258
- Inventors
- 39,993
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 9 | 0 |
| 1977 | 19 | 0 |
| 1978 | 26 | 0 |
| 1979 | 31 | 0 |
| 1980 | 36 | 0 |
| 1981 | 37 | 0 |
| 1982 | 32 | 0 |
| 1983 | 31 | 0 |
| 1984 | 49 | 0 |
| 1985 | 55 | 0 |
| 1986 | 63 | 0 |
| 1987 | 72 | 0 |
| 1988 | 56 | 0 |
| 1989 | 69 | 0 |
| 1990 | 62 | 0 |
| 1991 | 72 | 0 |
| 1992 | 64 | 0 |
| 1993 | 46 | 0 |
| 1994 | 36 | 0 |
| 1995 | 41 | 0 |
| 1996 | 71 | 0 |
| 1997 | 111 | 0 |
| 1998 | 129 | 0 |
| 1999 | 144 | 0 |
| 2000 | 188 | 0 |
| 2001 | 269 | 80 |
| 2002 | 324 | 497 |
| 2003 | 368 | 935 |
| 2004 | 347 | 1291 |
| 2005 | 370 | 1268 |
| 2006 | 508 | 1318 |
| 2007 | 622 | 1492 |
| 2008 | 672 | 1550 |
| 2009 | 783 | 1822 |
| 2010 | 1088 | 2046 |
| 2011 | 1077 | 1709 |
| 2012 | 1189 | 1734 |
| 2013 | 1305 | 1395 |
| 2014 | 1333 | 1609 |
| 2015 | 1084 | 1394 |
| 2016 | 998 | 1405 |
| 2017 | 1080 | 1311 |
| 2018 | 918 | 1117 |
| 2019 | 884 | 1009 |
| 2020 | 754 | 835 |
| 2021 | 567 | 681 |
| 2022 | 402 | 537 |
| 2023 | 322 | 435 |
| 2024 | 293 | 402 |
| 2025 | 247 | 318 |
| 2026 | 120 | 216 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Bifidobacterium longum CCFM1206 capable of producing sulforaphane and relieving inflammation6 Oct 2026US 12,751,980 B2Jiangnan University
- PHD inhibitor compounds, compositions, and use6 Oct 2026US 12,753,161 B2Akebia Therapeutics, Inc.
- Polypeptide compound and use thereof in treatment of enteritis29 Sep 2026US 12,747,267 B2Sichuan Gooddoctor Panxi Pharmaceutical Co., Ltd.
- Composition for preventing, ameliorating, or treating gastritis or peptic ulcer comprising anthocyanin-negatively charged polysaccharide complex as active ingredient22 Sep 2026US 12,741,029 B2Jbklab Co., Ltd.
- Therapeutic agents targeting GPR3522 Sep 2026US 12,741,968 B2Prometheus Biosciences, Inc.
- Linaprazan glurate for treating gastroesophageal reflux disease (gerd)8 Oct 2026US 2026/0306464 A1Cinclus Pharma Holding AB (Publ)
- Methods for treating gastrointestinal inflammatory diseases using alpha-ketoglutarate (akg) modulators1 Oct 2026US 2026/0294856 A1
- Topical composition for the treatment of mucosal lesions with short gelling time1 Oct 2026US 2026/0294959 A1Inmedical Therapeutics, S.L.
- Method of treating gastrointestinal inflammatory disease1 Oct 2026US 2026/0297197 A1Paragon Therapeutics, Inc.
- Methods of lyophilizing lipid nanoparticles24 Sep 2026US 2026/0283974 A1Takeda Pharmaceutical Company Limited
Most cited
By later US patents
- (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses1,031US 7,094,916 B2Wisconsin Alumni Research Foundation · 2006
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions930US 6,248,363 B1Lipocine Inc. · 2001
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions684US 6,923,988 B2Lipocine Inc. · 2005
- Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositions616US 6,569,463 B2Lipocine Inc. · 2003
- Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity604US 6,602,684 B1GlycArt Biotechnology AG · 2003